bioLytical focuses on the research, development and commercialization of rapid in vitro medical diagnostics. Using its proprietary 1-minute INSTI® technology platform, bioLytical’s product line features solutions for HIV, HCV, Syphilis and COVID-19.
Text
Cancel OK
